M Galotti

Lugano, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data.

The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2024

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update.

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 06, 2024

Reply to the Letter to the Editor regarding 'Overcoming Barriers in Biomarker Testing' J. García-Foncillas et al.

Reply to the Letter to the Editor regarding 'Overcoming Barriers in Biomarker Testing' J. García-Foncillas et al.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 22, 2024

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0.

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 03, 2023

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.

Journal: ESMO open
Published: April 11, 2023

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 13, 2023

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines.

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines.

Journal: ESMO open
Published: August 30, 2022

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey.

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey.

Journal: ESMO open
Published: August 03, 2022

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit.

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 02, 2022

Prioritising systemic cancer therapies applying ESMO's tools and other resources to assist in improving cancer care globally: the Kazakh experience.

Prioritising systemic cancer therapies applying ESMO's tools and other resources to assist in improving cancer care globally: the Kazakh experience.

Journal: ESMO open
Published: November 03, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026